Published Paper Details:

Invasive fungal infections (IFI) are now recognized as a serious global health threats placing a heavy burden on health care system. Treating thus infections is difficult because the available antifungal drugs often cause side effects , have limited effectiveness and face rising resistance. Over the past 30 years,researchers have carried out extensive testing of antifungal drugs.These efforts have been crucial in creating treatment guidelines for serious fungal infections. Most of these guidelines are based on well known and highly cited clinical trials. While we have made progress in developing antifungal medicines that are more effective and less toxic than older options .Early detections and targeted treatment This growing challenge highlights the urgent need for new antifungal medications. This review explores the latest advancements in antifungal drug development, focusing on innovative compounds that are either being tested in clinical trials or are likely to be evaluated soon. These new agents stand out because of their novel mechanisms of action, broader antimicrobial coverage, and improved pharmacokinetic properties. Together, these qualities hold promise for more effective treatment options than traditional drugs.